Media ReleasesCyclopharm

View All Cyclopharm News


Cyclopharm - Half Year 2020 Financial Results


Radiopharmaceutical company, Cyclopharm Limited (ASX:CYC) today announced financial report for the six month period to 30 June 2020, including sales revenue of $5.8 million, in line with  previous guidance, and a 0.5 cents per share dividend.

Key features of the financial results for the 2020 half year include...

For more information, download the attached PDF.

Download this document